EpiPen maker Mylan to pay $465M in settlement with U.S. government

Mylan NV on Friday said it will pay $465 million US to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program.

from CBC | Health News http://ift.tt/2cXNNeG